Cees Heiman - Bausch Health Senior Canada

BHC Stock  CAD 11.01  0.28  2.61%   

Executive

Cees Heiman is Senior Canada of Bausch Health Companies
Address 2150 St. ElzEar Boulevard West, Laval, QC, Canada, H7L 4A8
Phone514 744 6792
Webhttps://www.bauschhealth.com

Bausch Health Management Efficiency

The company has return on total asset (ROA) of 0.0415 % which means that it generated a profit of $0.0415 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (23.0454) %, meaning that it generated substantial loss on money invested by shareholders. Bausch Health's management efficiency ratios could be used to measure how well Bausch Health manages its routine affairs as well as how well it operates its assets and liabilities. As of the 13th of December 2024, Return On Equity is likely to grow to 0.61, though Return On Tangible Assets are likely to grow to (0.06). At this time, Bausch Health's Non Currrent Assets Other are very stable compared to the past year. As of the 13th of December 2024, Other Current Assets is likely to grow to about 1.2 B, while Total Assets are likely to drop about 14.9 B.
Bausch Health Companies has accumulated 22.39 B in total debt with debt to equity ratio (D/E) of 906.2, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Bausch Health Companies has a current ratio of 1.19, suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist Bausch Health until it has trouble settling it off, either with new capital or with free cash flow. So, Bausch Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bausch Health Companies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bausch to invest in growth at high rates of return. When we think about Bausch Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Sandy OnoOpen Text Corp
42
Jen BellOpen Text Corp
N/A
Peter IliopoulosGildan Activewear
54
Lalitha VaidyanathanCCL Industries
N/A
Wesley PEngWheaton Precious Metals
N/A
Curt LLBWheaton Precious Metals
56
Paul DugganOpen Text Corp
48
Emma MurrayWheaton Precious Metals
N/A
Joe BoxWaste Connections
N/A
Cosmin BalotaOpen Text Corp
50
Harry BlountOpen Text Corp
N/A
Denise MiuraOpen Text Corp
N/A
Nicolangelo VecchiarelliCCL Industries
N/A
Jason DeHaanGildan Activewear
N/A
Jessy HayemGildan Activewear
N/A
James SellorsCCL Industries
N/A
Gabrielle SukmanOpen Text Corp
N/A
Brian SweeneyOpen Text Corp
60
Ben LilienthalCCL Industries
N/A
Simona AntolakWheaton Precious Metals
N/A
Shannon BellOpen Text Corp
N/A
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. Bausch Health Companies Inc. was founded in 1983 and is headquartered in Laval, Canada. BAUSCH HEALTH operates under Drug Manufacturers - Specialty Generic classification in Canada and is traded on Toronto Stock Exchange. It employs 21100 people. Bausch Health Companies (BHC) is traded on Toronto Exchange in Canada and employs 20,270 people. Bausch Health is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Bausch Health Companies Leadership Team

Elected by the shareholders, the Bausch Health's board of directors comprises two types of representatives: Bausch Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bausch. The board's role is to monitor Bausch Health's management team and ensure that shareholders' interests are well served. Bausch Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bausch Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jeff Hartness, Commercial Access
Kathleen Fitzpatrick, Executive Officer
John Barresi, Controller, VP
Garen Sarafian, VP Relations
Arthur Shannon, IR Contact Officer
Jiny MBA, Senior Medical
Tage MD, Chief RD
William Woodfield, Senior Treasurer
Donald Pearl, Senior Dermatologics
Robert Butz, VP Affairs
JeanJacques Charhon, Chief Officer
Mirza Dautbegovic, Executive COO
Aimee Lenar, Executive Pharma
Seana Carson, Executive Counsel
Josh Coyle, Senior Salix
Graham Jackson, Senior Officer
Thomas Appio, President & Co-Head Bausch + Lomb/International
Thomas Vadaketh, Ex CFO
Cees Heiman, Senior Canada

Bausch Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bausch Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Bausch Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bausch Stock

  0.63ERC Eros Resources CorpPairCorr

Moving against Bausch Stock

  0.56AEMC Alaska Energy MetalsPairCorr
  0.35NZP Chatham Rock PhosphatePairCorr
The ability to find closely correlated positions to Bausch Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Health Companies to buy it.
The correlation of Bausch Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Health Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bausch Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.